EPISODE · Apr 5, 2022 · 31 MIN
EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?
from EASL Podcasts · host European Association for the Study of the Liver
Discover this EASL Studio podcast discussing the Baveno Consensus started over 30 years ago with the aim of reviewing current diagnostic and therapeutic strategies and producing updated definitions.But, with the extension of indication of non-selective beta blockers, has the consensus gone too far?Is there enough evidence for their use in already decompensated patients?How safe are they in this patient population?What do we know about the effects on refractory ascites? Circulatory dysfunction?Read moreAll EASL Studio Podcasts are available on EASL Campus.
Embed this episode
NOW PLAYING
EASL Studio Podcast: Betablockers in cirrhosis: Has Baveno consensus gone too far?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.